These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34504784)

  • 21. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
    Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
    Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
    Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and validation of a nomogram for predicting immune-related prognostic features in trunk melanoma-specific death.
    Chu Y; Hu S; Li S; Qi X
    Ann Transl Med; 2022 Dec; 10(24):1371. PubMed ID: 36660695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis.
    Wu XX; Chen RP; Chen RC; Gong HP; Wang BF; Li YL; Lin XR; Huang ZM
    J Thorac Dis; 2019 Jul; 11(7):2990-3003. PubMed ID: 31463129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.
    Lin J; Li X; Ding X; Chen Z; Wu Y; Zhao K
    Front Med (Lausanne); 2022; 9():960235. PubMed ID: 36425110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database.
    Han D; Yang J; Xu F; Huang Q; Bai L; Wei YL; Kaaya RE; Wang S; Lyu J
    Medicine (Baltimore); 2020 Jul; 99(31):e21322. PubMed ID: 32756116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis.
    Wang Y; Wu J; He H; Ma H; Hu L; Wen J; Lyu J
    Int J Colorectal Dis; 2020 May; 35(5):795-804. PubMed ID: 32078716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
    Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
    Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
    Zhang G; Wu B; Wang X; Li J
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
    Li W; Xiao Y; Xu X; Zhang Y
    Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomograms-based prediction of overall and cancer-specific survivals for patients diagnosed with major salivary gland carcinoma.
    Guo Z; Wang Z; Liu Y; Han J; Liu J; Zhang C
    Ann Transl Med; 2021 Aug; 9(15):1230. PubMed ID: 34532367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    Jiang AG; Cai X
    BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competing risks analysis of external versus internal radiation in patients with hepatocellular carcinoma after controlling for immortal time bias.
    Ku CY; Yang XK; Xi LJ; Wang RZ; Wu BB; Dai M; Liu L; Ping ZG
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9927-9935. PubMed ID: 37249648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
    Xu YB; Liu H; Cao QH; Ji JL; Dong RR; Xu D
    Cancer Med; 2020 Jun; 9(12):4095-4106. PubMed ID: 32314546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram Predicting Cause-Specific Mortality in Nonmetastatic Male Breast Cancer: A Competing Risk Analysis.
    Sun W; Cheng M; Zhou H; Huang W; Qiu Z
    J Cancer; 2019; 10(3):583-593. PubMed ID: 30719155
    [No Abstract]   [Full Text] [Related]  

  • 37. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
    Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
    Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
    Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
    BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram to Predict Cancer-Specific Survival in Patients with Pancreatic Acinar Cell Carcinoma: A Competing Risk Analysis.
    He C; Zhang Y; Cai Z; Duan F; Lin X; Li S
    J Cancer; 2018; 9(22):4117-4127. PubMed ID: 30519311
    [No Abstract]   [Full Text] [Related]  

  • 40. Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer.
    Lu X; Li X; Ling H; Gong Y; Guo L; He M; Sun H; Hu X
    Med Sci Monit; 2020 Sep; 26():e925210. PubMed ID: 32920589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.